A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment

PURPOSE: Raloxifene is a selective estrogen receptor modulator (SERM), and raloxifene treatment for osteoporosis is reimbursable under the Korean National Health Insurance. Evidence suggests that SERMs use reduces the risk of breast cancer in Asian population. Herein, we retrospectively investigated...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Breast Cancer
Main Authors: Lee, Jihyoun, Lee, Ji Sung, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Choi, Young Jin, Park, Sungmin
Format: Artigo
Jezik:Inglês
Izdano: Korean Breast Cancer Society 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250100/
https://ncbi.nlm.nih.gov/pubmed/34128366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e28
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki